Neuro Oncology OUP: Most-Cited Full-Text Articles
http://neuro-oncology.dukejournals.org/
Most-cited rankings are recalculated at the beginning of the month and are based on citations to articles on this journal site from articles in other HighWire-hosted journals.2009-11-09<![CDATA[Primary and secondary glioblastomas: From concept to clinical diagnosis]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/1/1/44?rss=1&ssource=mfc
Jan 1, 1999; 1:44-51 Symposium Genetic Classification and Treatment of Malignant Gliomas and Oligodendrogliomas]]>Paul Kleihues, Hiroko Ohgaki1999-01-0110.1215/15228517-1-1-44Duke University Press<![CDATA[Epidemiology of primary brain tumors: Current concepts and review of the literature]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/4/4/278?rss=1&ssource=mfc
Oct 1, 2002; 4:278-299 ]]>Margaret Wrensch, Yuriko Minn, Terri Chew, Melissa Bondy, Mitchel S. Berger2002-10-0110.1215/15228517-4-4-278Duke University Press<![CDATA[The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/7/2/122?rss=1&ssource=mfc
Apr 1, 2005; 7:122-133 Tumor Biology]]>Daniel J. Brat, Anita C. Bellail, Erwin G. Van Meir2005-04-0110.1215/S1152851704001061Duke University Press<![CDATA[A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/5/2/79?rss=1&ssource=mfc
Apr 1, 2003; 5:79-88 ]]>Manfred Westphal, Dana C. Hilt, Enoch Bortey, Patrick Delavault, Robert Olivares, Peter C. Warnke, Ian R. Whittle, Juha Jaaskelainen, Zvi Ram2003-04-0110.1215/15228517-5-2-79Duke University Press<![CDATA[Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/7/2/164?rss=1&ssource=mfc
Apr 1, 2005; 7:164-176 Molecular Genetics]]>Caterina Giannini, Jann N. Sarkaria, Atsushi Saito, Joon H. Uhm, Evanthia Galanis, Brett L. Carlson, Mark A. Schroeder, C. David James2005-04-0110.1215/S1152851704000821Duke University Press<![CDATA[The role of pericytes in blood-vessel formation and maintenance]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/7/4/452?rss=1&ssource=mfc
Oct 1, 2005; 7:452-464 Symposium on Angiogenesis, Part 2]]>Gabriele Bergers, Steven Song2005-10-0110.1215/S1152851705000232Duke University Press<![CDATA[Medulloblastoma: Clinical and biologic aspects]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/1/3/232?rss=1&ssource=mfc
Jul 1, 1999; 1:232-250 Symposia Childhood Brain Tumors]]>Roger J. Packer, Philip Cogen, Gilbert Vezina, Lucy B. Rorke1999-07-0110.1215/15228517-1-3-232Duke University Press<![CDATA[Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/8/1/67?rss=1&ssource=mfc
Jan 1, 2006; 8:67-78 Clinical Therapy Trials—Drug]]>Michael D. Prados, Kathleen R. Lamborn, Susan Chang, Eric Burton, Nicholas Butowski, Mary Malec, Ami Kapadia, Jane Rabbitt, Margaretta S. Page, Ann Fedoroff, Dong Xie, Sean K. Kelley2006-01-0110.1215/S1522851705000451Duke University Press<![CDATA[Descriptive epidemiology of primary brain and CNS tumors: Results from the Central Brain Tumor Registry of the United States, 1990-1994]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/1/1/14?rss=1&ssource=mfc
Jan 1, 1999; 1:14-25 Epidemiology and Cancer Control]]>Tanya S. Surawicz, Bridget J. McCarthy, Varant Kupelian, Patti J. Jukich, Janet M. Bruner, Faith G. Davis, the collaborating registries of the Central Brain Tumor Registry of the United States1999-01-0110.1215/15228517-1-1-14Duke University Press<![CDATA[A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/8/2/189?rss=1&ssource=mfc
Apr 1, 2006; 8:189-193 Clinical Therapy Trials—Drug]]>Michael D. Prados, Kathleen Lamborn, W.K.A. Yung, Kurt Jaeckle, H. Ian Robins, Minesh Mehta, Howard A. Fine, Patrick Y. Wen, Timothy Cloughesy, Susan Chang, M. Kelly Nicholas, David Schiff, Harry Greenberg, Larry Junck, Karen Fink, Ken Hess, John Kuhn2006-04-01Duke University Press<![CDATA[Response and progression in recurrent malignant glioma]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/1/4/282?rss=1&ssource=mfc
Oct 1, 1999; 1:282-288 ]]>Kenneth R. Hess, Eric T. Wong, Kurt A. Jaeckle, Athanassios P. Kyritsis, Victor A. Levin, Michael D. Prados, W. K. Alfred Yung1999-10-0110.1215/15228517-1-4-282Duke University Press<![CDATA[Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/7/2/134?rss=1&ssource=mfc
Apr 1, 2005; 7:134-153 Tumor Biology]]>Balveen Kaur, Fatima W. Khwaja, Eric A. Severson, Shannon L. Matheny, Daniel J. Brat, Erwin G. Van Meir2005-04-0110.1215/S1152851704001115Duke University Press<![CDATA[The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/2/1/45?rss=1&ssource=mfc
Jan 1, 2000; 2:45-59 Review Article]]>Dennis R. Groothuis2000-01-0110.1215/15228517-2-1-45Duke University Press<![CDATA[Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: Final report of NABTT 97-11]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/6/1/21?rss=1&ssource=mfc
Jan 1, 2004; 6:21-27 Clinical Investigations]]>Tracy T. Batchelor, Mark R. Gilbert, Jeffrey G. Supko, Kathryn A. Carson, Louis B. Nabors, Stuart A. Grossman, Glenn J. Lesser, Tom Mikkelsen, Surasak Phuphanich, for the NABTT CNS Consortium2004-01-0110.1215/S1152851703000218Duke University Press<![CDATA[Pten signaling in gliomas]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/4/3/196?rss=1&ssource=mfc
Jul 1, 2002; 4:196-211 Molecular Genetics]]>Christiane B. Knobbe, Adrian Merlo, Guido Reifenberger2002-07-0110.1215/15228517-4-3-196Duke University Press<![CDATA[Limitations of stereotactic biopsy in the initial management of gliomas]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/3/3/193?rss=1&ssource=mfc
Jul 1, 2001; 3:193-200 ]]>Robert J. Jackson, Gregory N. Fuller, Dima Abi-Said, Frederick F. Lang, Ziya L. Gokaslan, Wei Ming Shi, David M. Wildrick, Raymond Sawaya2001-07-0110.1215/15228517-3-3-193Duke University Press<![CDATA[Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/10/2/162?rss=1&ssource=mfc
Apr 1, 2008; 10:162-170 Clinical Investigations]]>Kathleen R. Lamborn, W. K. Alfred Yung, Susan M. Chang, Patrick Y. Wen, Timothy F. Cloughesy, Lisa M. DeAngelis, H. Ian Robins, Frank S. Lieberman, Howard A. Fine, Karen L. Fink, Larry Junck, Lauren Abrey, Mark R. Gilbert, Minesh Mehta, John G. Kuhn, Kenneth D. Aldape, Janelle Hibberts, Pamela M. Peterson, Michael D. Prados, North American Brain Tumor Consortium2008-04-01Duke University Press<![CDATA[Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysis]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/6/3/227?rss=1&ssource=mfc
Jul 1, 2004; 6:227-235 Clinical Neuro-Oncology]]>Kathleen R. Lamborn, Susan M. Chang, Michael D. Prados2004-07-0110.1215/S1152851703000620Duke University Press<![CDATA[The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/9/1/29?rss=1&ssource=mfc
Jan 1, 2007; 9:29-38 Clinical Investigations]]>Karla V. Ballman, Jan C. Buckner, Paul D. Brown, Caterina Giannini, Patrick J. Flynn, Betsy R. LaPlant, Kurt A. Jaeckle2007-01-01Duke University Press<![CDATA[Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/7/4/436?rss=1&ssource=mfc
Oct 1, 2005; 7:436-451 Tumor Biology]]>Roger Abounader, John Laterra2005-10-0110.1215/S1152851705000050Duke University Press<![CDATA[A phase II study of extended low-dose temozolomide in recurrent malignant gliomas]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/4/1/39?rss=1&ssource=mfc
Jan 1, 2002; 4:39-43 ]]>Raja B. Khan, Jeffrey J. Raizer, Mark G. Malkin, Kimberley A. Bazylewicz, Lauren E. Abrey2002-01-0110.1215/15228517-4-1-39Duke University Press<![CDATA[Trends in incidence of primary brain tumors in the United States, 1985-1994]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/3/3/141?rss=1&ssource=mfc
Jul 1, 2001; 3:141-151 Epidemiology and Cancer Control]]>Patti J. Jukich, Bridget J. McCarthy, Tanya S. Surawicz, Sally Freels, Faith G. Davis2001-07-0110.1215/15228517-3-3-141Duke University Press<![CDATA[Multifaceted end points in brain tumor clinical trials: Cognitive deterioration precedes MRI progression]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/5/2/89?rss=1&ssource=mfc
Apr 1, 2003; 5:89-95 Clinical Neuro-Oncology]]>Christina A. Meyers, Kenneth R. Hess2003-04-0110.1215/15228517-5-2-89Duke University Press<![CDATA[Expression and hypoxic regulation of angiopoietins in human astrocytomas]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/3/1/1?rss=1&ssource=mfc
Jan 1, 2001; 3:1-10 Molecular Genetics]]>Hao Ding, Luba Roncari, Xiaoli Wu, Nelson Lau, Patrick Shannon, Andras Nagy, Abhijit Guha2001-01-0110.1215/15228517-3-1-1Duke University Press<![CDATA[Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/1/2/109?rss=1&ssource=mfc
Apr 1, 1999; 1:109-119 Tumor Biology]]>Hirofumi Hirano, M. Beatriz S. Lopes, Edward R. Laws Jr., Tetsuhiko Asakura, Masamichi Goto, Joan E. Carpenter, Larry R. Karns, Scott R. VandenBerg1999-04-0110.1215/15228517-1-2-109Duke University Press<![CDATA[High-dose methotrexate for primary CNS lymphoma in the elderly]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/2/1/40?rss=1&ssource=mfc
Jan 1, 2000; 2:40-44 Clinical Therapy Trials—Drug]]>Siobhan Ng, Mark A. Rosenthal, David Ashley, Lawrence Cher2000-01-0110.1215/15228517-2-1-40Duke University Press<![CDATA[O6-Benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/6/1/28?rss=1&ssource=mfc
Jan 1, 2004; 6:28-32 Clinical Investigations]]>S. Clifford Schold Jr., Demetrius M. Kokkinakis, Susan M. Chang, Mitchel S. Berger, Kenneth R. Hess, David Schiff, H. Ian Robins, Minesh P. Mehta, Karen L. Fink, R.L. Davis, Michael D. Prados2004-01-0110.1215/S115285170300019XDuke University Press<![CDATA[Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/3/3/152?rss=1&ssource=mfc
Jul 1, 2001; 3:152-158 Epidemiology and Cancer Control]]>Faith G. Davis, Varant Kupelian, Sally Freels, Bridget McCarthy, Tanya Surawicz2001-07-0110.1215/15228517-3-3-152Duke University Press<![CDATA[SETA: A novel SH3 domain-containing adapter molecule associated with malignancy in astrocytes]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/2/1/6?rss=1&ssource=mfc
Jan 1, 2000; 2:6-15 Tumor Biology]]>Oliver Bogler, Frank B. Furnari, Andrea Kindler-Roehrborn, Virginia W. Sykes, Richard Yung, H.-J. Su Huang, Webster K. Cavenee2000-01-0110.1215/15228517-2-1-6Duke University Press<![CDATA[Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/6/1/44?rss=1&ssource=mfc
Jan 1, 2004; 6:44-54 Clinical Investigations]]>Michael D. Prados, W.K.A. Yung, Kurt A. Jaeckle, H. Ian Robins, Minesh P. Mehta, Howard A. Fine, Patrick Y. Wen, Timothy F. Cloughesy, Susan M. Chang, M. Kelly Nicholas, David Schiff, Harry S. Greenberg, Larry Junck, Karen L. Fink, Kenneth R. Hess, John Kuhn2004-01-0110.1215/S1152851703000292Duke University Press<![CDATA[Expression of the splicing regulator polypyrimidine tract-binding protein in normal and neoplastic brain]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/6/1/9?rss=1&ssource=mfc
Jan 1, 2004; 6:9-14 Neuropathology]]>Ian E. McCutcheon, Stephen J. Hentschel, Gregory N. Fuller, Wei Jin, Gilbert J. Cote2004-01-0110.1215/S1152851703000279Duke University Press<![CDATA[A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/4/4/261?rss=1&ssource=mfc
Oct 1, 2002; 4:261-267 Medical Neuro-Oncology]]>Mark R. Gilbert, Henry S. Friedman, John F. Kuttesch, Michael D. Prados, Jeffrey J. Olson, Gregory H. Reaman, Sara L. Zaknoen2002-10-0110.1215/15228517-4-4-261Duke University Press<![CDATA[The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/8/3/261?rss=1&ssource=mfc
Jul 1, 2006; 8:261-279 Immunology]]>S. Farzana Hussain, David Yang, Dima Suki, Kenneth Aldape, Elizabeth Grimm, Amy B. Heimberger2006-07-01Duke University Press<![CDATA[Sustained radiographic and clinical response in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the recombinant targeted toxin TP-38: Case study]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/7/1/90?rss=1&ssource=mfc
Jan 1, 2005; 7:90-96 Clinical Therapy Trials]]>John H. Sampson, David A. Reardon, Allan H. Friedman, Henry S. Friedman, R. Edward Coleman, Roger E. McLendon, Ira Pastan, Darell D. Bigner2005-01-0110.1215/S1152851703000589Duke University Press<![CDATA[A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/7/1/64?rss=1&ssource=mfc
Jan 1, 2005; 7:64-76 Clinical Investigations]]>Paul Klimo Jr., Clinton J. Thompson, John R.W. Kestle, Meic H. Schmidt2005-01-0110.1215/S1152851704000262Duke University Press<![CDATA[Induction of membrane-type-1 matrix metalloproteinase by epidermal growth factor-mediated signaling in gliomas]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/6/3/188?rss=1&ssource=mfc
Jul 1, 2004; 6:188-199 Tumor Biology]]>Timothy E. Van Meter, William C. Broaddus, Harcharan K. Rooprai, Geoffrey J. Pilkington, Helen L. Fillmore2004-07-0110.1215/S1152851703000486Duke University Press<![CDATA[Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: The Duke experience]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/4/2/102?rss=1&ssource=mfc
Apr 1, 2002; 4:102-108 Clinical Therapy Trails-Other]]>Christopher D. Turner, Sridharan Gururangan, James Eastwood, Krystal Bottom, Melody Watral, Rodney Beason, Roger E. McLendon, Allan H. Friedman, Sandra Tourt-Uhlig, Langdon L. Miller, Henry S. Friedman2002-04-0110.1215/15228517-4-2-102Duke University Press<![CDATA[Accumulation of 8-oxo-2'-deoxyguanosine and increased expression of hMTH1 protein in brain tumors]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/3/2/73?rss=1&ssource=mfc
Apr 1, 2001; 3:73-81 Neuropathology]]>Takashi Iida, Akiko Furuta, Masatou Kawashima, Jun-ichi Nishida, Yusaku Nakabeppu, Toru Iwaki2001-04-0110.1215/15228517-3-2-73Duke University Press<![CDATA[The treatment of malignant brain tumors in infants and very young children: An update of the Pediatric Oncology Group experience]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/1/2/152?rss=1&ssource=mfc
Apr 1, 1999; 1:152-161 ]]>Patricia K. Duffner, Marc E. Horowitz, Jeffrey P. Krischer, Peter C. Burger, Michael E. Cohen, Robert A. Sanford, Henry S. Friedman, Larry E. Kun, the Pediatric Oncology Group (POG)1999-04-0110.1215/15228517-1-2-152Duke University Press<![CDATA[Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/1/2/124?rss=1&ssource=mfc
Apr 1, 1999; 1:124-137 Review]]>Michimasa Nozaki, Mitsuhiro Tada, Hiroyuki Kobayashi, Chang-Liang Zhang, Yutaka Sawamura, Hiroshi Abe, Nobuaki Ishii, Erwin G. Van Meir1999-04-0110.1215/15228517-1-2-124Duke University Press<![CDATA[Comparative genetic patterns of glioblastoma multiforme: Potential diagnostic tool for tumor classification]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/2/3/164?rss=1&ssource=mfc
Jul 1, 2000; 2:164-173 Molecular Genetics]]>Rodney N. Wiltshire, B.K. Ahmed Rasheed, Henry S. Friedman, Allan H. Friedman, Sandra H. Bigner2000-07-0110.1215/15228517-2-3-164Duke University Press<![CDATA[Analysis of genomic rearrangements associated with EGFRvIII expression suggests involvement of Alu repeat elements]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/2/3/159?rss=1&ssource=mfc
Jul 1, 2000; 2:159-163 Molecular Genetics]]>Lori Frederick, Greg Eley, Xiao-Yang Wang, C. David James2000-07-0110.1215/15228517-2-3-159Duke University Press<![CDATA[Neurolymphomatosis]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/5/2/104?rss=1&ssource=mfc
Apr 1, 2003; 5:104-115 Retrospective Clinical Studies]]>Joachim M. Baehring, Denise Damek, Emily C. Martin, Rebecca A. Betensky, Fred H. Hochberg2003-04-0110.1215/15228517-5-2-104Duke University Press<![CDATA[A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/5/2/96?rss=1&ssource=mfc
Apr 1, 2003; 5:96-103 Clinical Investigations]]>Michael D. Prados, S. Clifford Schold Jr., Howard A. Fine, Kurt Jaeckle, Fred Hochberg, Laszlo Mechtler, Michael R. Fetell, Surasak Phuphanich, Lynn Feun, Todd J. Janus, Kathleen Ford, William Graney2003-04-0110.1215/15228517-5-2-96Duke University Press<![CDATA[Toward better early-phase brain tumor clinical trials: A reappraisal of current methods and proposals for future strategies]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/4/4/268?rss=1&ssource=mfc
Oct 1, 2002; 4:268-277 Clinical Therapy Trails-Other]]>Frederick F. Lang, Mark R. Gilbert, Vinay K. Puduvalli, Jeffrey Weinberg, Victor A. Levin, W.K. Alfred Yung, Raymond Sawaya, Gregory N. Fuller, Charles A. Conrad2002-10-0110.1215/15228517-4-4-268Duke University Press<![CDATA[MDM2 overexpression is associated with short survival in adults with medulloblastoma]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/4/2/115?rss=1&ssource=mfc
Apr 1, 2002; 4:115-122 ]]>Maria Teresa Giordana, Debora Duo, Sabrina Gasverde, Elisa Trevisan, Andrea Boghi, Isabella Morra, Luca Pradotto, Alessandro Mauro, Adriano Chio2002-04-0110.1215/15228517-4-2-115Duke University Press<![CDATA[Histone acetylation may suppress human glioma cell proliferation when p21WAF/Cip1 and gelsolin are induced]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/4/2/95?rss=1&ssource=mfc
Apr 1, 2002; 4:95-101 Tumor Biology]]>Hideki Kamitani, Seijiro Taniura, Kenji Watanabe, Makoto Sakamoto, Takashi Watanabe, Thomas Eling2002-04-0110.1215/15228517-4-2-95Duke University Press<![CDATA[Carboplatin is effective therapy for young children with progressive optic pathway tumors: A Pediatric Oncology Group phase II study]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/2/4/213?rss=1&ssource=mfc
Oct 1, 2000; 2:213-220 Pediatric Neuro-Oncology]]>Donald H. Mahoney Jr., Michael E. Cohen, Henry S. Friedman, James L. Kepner, Linda Gemer, James W. Langston, Hector E. James, Patricia K. Duffner, Larry E. Kun2000-10-0110.1215/15228517-2-4-213Duke University Press<![CDATA[Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/9/4/412?rss=1&ssource=mfc
Oct 1, 2007; 9:412-423 Basic and Translational Investigations]]>Sophie de Bouard, Paulette Herlin, James G. Christensen, Edwige Lemoisson, Pascal Gauduchon, Eric Raymond, Jean-Sebastien Guillamo2007-10-01Duke University Press<![CDATA[Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: A Pediatric Brain Tumor Consortium report]]>
http://neuro-oncology.dukejournals.org/cgi/content/short/9/2/145?rss=1&ssource=mfc
Apr 1, 2007; 9:145-160 Special Focus: Pediatric Neuro-Oncology]]>Ian F. Pollack, Regina I. Jakacki, Susan M. Blaney, Michael L. Hancock, Mark W. Kieran, Peter Phillips, Larry E. Kun, Henry Friedman, Roger Packer, Anu Banerjee, J. Russell Geyer, Stewart Goldman, Tina Young Poussaint, Matthew J. Krasin, Yanfeng Wang, Michael Hayes, Anthony Murgo, Susan Weiner, James M. Boyett2007-04-01Duke University Press